Verification evidence is still being completed.
PDF / print export
2cureX
Copenhagen, Denmark
- Verified lead
- Ole Thastrup
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Precision Oncology, Functional Diagnostics, Drug Sensitivity Testing, Personalized Medicine, and Cancer Diagnostics
- Review cycle
- May 2026
- Full address
- Fruebjergvej 3, 2100 Copenhagen, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official 2cureX contact page confirming the Copenhagen address.
- Editorial note
- 2cureX is published because official company materials confirm current leadership, Copenhagen operating address, and a clear precision-oncology diagnostics platform.
Precision Oncology, Functional Diagnostics, Drug Sensitivity Testing, Personalized Medicine, and Cancer Diagnostics
Official leadership disclosure, Official Copenhagen address disclosure, Diagnostics platform claim
2cureX is published because official company materials confirm current leadership, Copenhagen operating address, and a clear precision-oncology diagnostics platform.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Copenhagen, Denmark
2cureX
Precision Oncology, Functional Diagnostics, Drug Sensitivity Testing, Personalized Medicine, and Cancer Diagnostics · Diagnostics platform
2cureX runs precision oncology diagnostics, drug sensitivity testing, and clinical decision support platform in Copenhagen, Denmark.
- Lead
- Ole Thastrup (verified ↗)
- Address
- Fruebjergvej 3, 2100 Copenhagen, Denmark (source ↗)
- Compliance
- Not yet on record
- Last reviewed
- 22 Mar 2026 (2mo ago)
- Scale
- Diagnostics platform
- Capabilities
- Precision Oncology Diagnostics · Drug Sensitivity Testing · Clinical Decision Support Platform
- Founded
- 2005
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Ole Thastrup
CEO
Full addressFruebjergvej 3, 2100 Copenhagen, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Diagnostics platform
Copenhagen, Denmark. Precision Oncology, Functional Diagnostics, Drug Sensitivity Testing, Personalized Medicine, and Cancer Diagnostics. Review completed on 22 Mar 2026.
Danish diagnostics and medical-technology oversight
Official leadership disclosure, Official Copenhagen address disclosure, Diagnostics platform claim
Precision Oncology, Functional Diagnostics, Drug Sensitivity Testing, Personalized Medicine, and Cancer Diagnostics
2cureX is published because official company materials confirm current leadership, Copenhagen operating address, and a clear precision-oncology diagnostics platform.
Editorial note
2cureX is published because official company materials confirm current leadership, Copenhagen operating address, and a clear precision-oncology diagnostics platform.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Precision Oncology Diagnostics
Drug Sensitivity Testing
Clinical Decision Support Platform
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Functional testing workflow
Precision diagnostics systems
Clinical support infrastructure
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- REVIEW IN PROGRESS 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
22 Mar 2026: Executive identity confirmed via official management disclosure.
22 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is 2cureX located?
- 2cureX operates from Fruebjergvej 3, 2100 Copenhagen, Denmark, Copenhagen, Denmark.
- Who runs 2cureX?
- 2cureX is led by Ole Thastrup, CEO. Verified 22 Mar 2026.
- What does 2cureX do?
- 2cureX runs precision oncology diagnostics, drug sensitivity testing, and clinical decision support platform in Copenhagen, Denmark. Core capabilities: Precision Oncology Diagnostics, Drug Sensitivity Testing, Clinical Decision Support Platform.
Editorial context
Related technical briefs
Briefs that name Copenhagen as a covered market or city.